Literature DB >> 20043993

Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion.

Yu Wu1, Shengli Zhou, Cynthia M Smas.   

Abstract

Obesity is a public health crisis in the United States. Targeting preadipocyte to adipocyte conversion may be an effective approach to regulate adipose mass. Using differential screening we identified Fstl1, a secreted glycoprotein with roles in immunomodulation, cell growth, cardioprotection, and vascularization, as a "preadipokine". Fstl1 is highly expressed in 3T3-L1 preadipocytes and dramatically downregulated early in their differentiation to adipocytes. Northern blot analysis of murine tissues reveals white adipose tissue (WAT), lung and heart as primary sites of Fstl1 transcript expression. In WAT, Fstl1 transcript is restricted to the preadipocyte-containing stromal-vascular cell population. Time course studies in multiple adipogenesis models reveal downregulation of Fstl1 is a hallmark of white and brown adipocyte conversion. By Western blot, we show culture media of 3T3-L1 preadipocytes contains high levels of Fstl1 protein that rapidly decline in adipocyte conversion. Moreover, we observe a correlation between preadipocyte phenotype and Fstl1 expression in that TNFalpha-mediated de-differentiation of 3T3-L1 adipocytes is accompanied by re-expression of Fstl1 transcript and protein. Treatment of 3T3-L1 preadipocytes with a panel of 18 hormones and other agents revealed the demethylating agent 5-aza-cytidine decreases Fstl1 transcript and protein levels by approximately 90%. Furthermore, of 10 additional preadipocyte-expressed genes analyzed we find Pref-1, Col1A1, Sca-1/Ly6a, Lox and Thbs2, are also downregulated by 5-aza-cytidine. Using luciferase reporter constructs containing 791 or 3922 bp of the Fstl1 5' flanking region, we determine negative transcriptional regulation by Kruppel-like factor 15. Together, our data suggest downregulation of Fstl1 expression may be an important feature of preadipocyte to adipocyte conversion. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fstl1; Preadipocyte; Tsc-36; adipogenesis; adipose tissue; differentiation; obesity; secreted factor

Mesh:

Substances:

Year:  2010        PMID: 20043993      PMCID: PMC2849861          DOI: 10.1016/j.mod.2009.12.003

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  137 in total

1.  Flik, a chick follistatin-related gene, functions in gastrular dorsalisation/neural induction and in subsequent maintenance of midline Sonic hedgehog signalling.

Authors:  P Towers; K Patel; S Withington; A Isaac; J Cooke
Journal:  Dev Biol       Date:  1999-10-15       Impact factor: 3.582

2.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

Authors:  Z Cao; R M Umek; S L McKnight
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

3.  Identification and importance of brown adipose tissue in adult humans.

Authors:  Aaron M Cypess; Sanaz Lehman; Gethin Williams; Ilan Tal; Dean Rodman; Allison B Goldfine; Frank C Kuo; Edwin L Palmer; Yu-Hua Tseng; Alessandro Doria; Gerald M Kolodny; C Ronald Kahn
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

4.  Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay.

Authors:  Christian Widera; Rüdiger Horn-Wichmann; Tibor Kempf; Kerstin Bethmann; Beate Fiedler; Sarita Sharma; Ralf Lichtinghagen; Holger Leitolf; Boris Ivandic; Hugo A Katus; Evangelos Giannitsis; Kai C Wollert
Journal:  Clin Chem       Date:  2009-07-02       Impact factor: 8.327

Review 5.  New developments in adipogenesis.

Authors:  Martina I Lefterova; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2009-03-09       Impact factor: 12.015

6.  Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis.

Authors:  Queeny K Y Chan; Hextan Y S Ngan; Philip P C Ip; Vincent W S Liu; W C Xue; Annie N Y Cheung
Journal:  Carcinogenesis       Date:  2008-09-16       Impact factor: 4.944

7.  Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-gamma depletion to revert the adipocyte phenotype.

Authors:  Michael Schupp; Ana G Cristancho; Martina I Lefterova; Elyisha A Hanniman; Erika R Briggs; David J Steger; Mohammed Qatanani; Joshua C Curtin; Jonathan Schug; Scott A Ochsner; Neil J McKenna; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

8.  MicroRNA let-7 regulates 3T3-L1 adipogenesis.

Authors:  Tingwan Sun; Mingui Fu; Angie L Bookout; Steven A Kliewer; David J Mangelsdorf
Journal:  Mol Endocrinol       Date:  2009-03-26

9.  MicroRNA expression in human omental and subcutaneous adipose tissue.

Authors:  Nora Klöting; Susan Berthold; Peter Kovacs; Michael R Schön; Mathias Fasshauer; Karen Ruschke; Michael Stumvoll; Matthias Blüher
Journal:  PLoS One       Date:  2009-03-04       Impact factor: 3.240

10.  MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity.

Authors:  Huangming Xie; Bing Lim; Harvey F Lodish
Journal:  Diabetes       Date:  2009-02-02       Impact factor: 9.461

View more
  21 in total

1.  Structural and functional study of FK domain of Fstl1.

Authors:  Xinxin Li; Lian Li; Yue Chang; Wen Ning; Xinqi Liu
Journal:  Protein Sci       Date:  2019-08-09       Impact factor: 6.725

2.  Blocking follistatin-like 1 attenuates liver fibrosis in mice by regulating transforming growth factor-beta signaling.

Authors:  Xiao-Hua Zhang; Yong Chen; Bin Li; Ji-Yong Liu; Chong-Mei Yang; Ming-Ze Ma
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 3.  Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure.

Authors:  Nader Zamani; Chester W Brown
Journal:  Endocr Rev       Date:  2010-12-20       Impact factor: 19.871

Review 4.  BMPs and their clinical potentials.

Authors:  Meejung Kim; Senyon Choe
Journal:  BMB Rep       Date:  2011-10       Impact factor: 4.778

Review 5.  Follistatin-like 1 and its paralogs in heart development and cardiovascular disease.

Authors:  Martin Horak; DeLisa Fairweather; Piia Kokkonen; David Bednar; Julie Bienertova-Vasku
Journal:  Heart Fail Rev       Date:  2022-07-22       Impact factor: 4.654

6.  LAMC1-mediated preadipocytes differentiation promoted peritoneum pre-metastatic niche formation and gastric cancer metastasis.

Authors:  Yan Fang; Rongzhang Dou; Sihao Huang; Lei Han; Hang Fu; Chaogang Yang; Jialin Song; Jinsen Zheng; Xinyao Zhang; Keshu Liu; Zhenxian Xiang; Xinghua Zhang; Shuyi Wang; Bin Xiong
Journal:  Int J Biol Sci       Date:  2022-04-24       Impact factor: 10.750

Review 7.  Beyond the bone: Bone morphogenetic protein signaling in adipose tissue.

Authors:  Ana M Blázquez-Medela; Medet Jumabay; Kristina I Boström
Journal:  Obes Rev       Date:  2019-01-04       Impact factor: 9.213

8.  RNA-Seq Analysis of Abdominal Fat Reveals Differences between Modern Commercial Broiler Chickens with High and Low Feed Efficiencies.

Authors:  Zhu Zhuo; Susan J Lamont; William R Lee; Behnam Abasht
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

Review 9.  Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise.

Authors:  Silja Raschke; Jürgen Eckel
Journal:  Mediators Inflamm       Date:  2013-06-03       Impact factor: 4.711

10.  Follistatin-like 1: a potential mediator of inflammation in obesity.

Authors:  Nengguang Fan; Haiyan Sun; Yufan Wang; Yifei Wang; Lijuan Zhang; Zhenhua Xia; Liang Peng; Yanqiang Hou; Weiqin Shen; Rui Liu; Jiajing Yin; Yongde Peng
Journal:  Mediators Inflamm       Date:  2013-11-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.